← Evidence map

ReviewAmerican journal of clinical and experimental urology2023

Resveratrol used as nanotherapeutic: a promising additional therapeutic tool against hormone-sensitive, hormone-insensitive and resistant prostate cancer.

Jasmin Katrin BadawiPubMed ↗Full text ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36923720